Price $27.62 |
Market Cap
38.1B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
88.5
|
P/B
5.37
|
P/S
4.41
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
99.1
|
Op. Cash Flow
970K
|
FCF
0.2
|
|
Op. Margin
6.00%
|
Net Margin
5.10%
|
ROE
6.60%
|
ROI
5.10%
|
|
ROA
2.40%
|
EPS Growth
-
|
Current Ratio
0.9
|
Debt/Equity
80.50%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Depomed Inc (DEPO) | $10.60 | - | - | 669.5M | Strong Buy |
| Valeant Pharmaceuticals Intl I (VRX) | $17.50 | - | - | 5.89B | Strong Buy |
| Alere Inc (ALR) | $50.47 | - | - | 4.38B | Strong Buy |
| BioLife Solutions Inc (BLFS) | $3.21 | - | - | 30.8M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.38 | - | - | 12.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
